Anton Egorov
3PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jun 02, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial.Javier Cortés, Sara A Hurvitz, Seock-Ah Im
|Dec 28, 2019
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306).Ruth Pettengell, Monika Długosz-Danecka, David Andorsky
|Mar 23, 2018
Long-Term Response and Remission with Pixantrone in Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma: Post-Hoc Analysis of the Multicenter, Open-Label, Randomized PIX301 Trial.Ruth Pettengell, Bertrand Coiffier, Anton Egorov
Pageof 1
Frequent Collaborators
1 joint publications
David Andorsky
1 joint publications
Javier Cortés
1 joint publications
Giuseppe Curigliano
1 joint publications
Joanne W Y Chiu
1 joint publications
Kan Yonemori
1 joint publications
Giampaolo Bianchini
1 joint publications
Sherene Loi
1 joint publications
Thomas Bachelot
1 joint publications
Erika Hamilton
